EXHIBIT 6

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the ordinary shares of China Biologic Products Holdings, Inc., and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13D and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to

believe that such information is inaccurate. This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

[Remainder of this page has been left intentionally blank.]

Signature Page

IN WITNESS WHEREOF, the undersigned have executed this Joint Filing Agreement as of September 30, 2019.

TEMASEK HOLDINGS (PRIVATE) LIMITED
By:	/s/ Andrew Ang Lye Whatt
	Name: Andrew Ang Lye Whatt
	Title: Authorised Signatory

FULLERTON MANAGEMENT PTE LTD
By:	/s/ Cheong Kok Tim
	Name: Cheong Kok Tim
	Title: Director

TEMASEK LIFE SCIENCES PRIVATE LIMITED
By:	/s/ Lim Siew Lee Sherlyn
	Name: Lim Siew Lee Sherlyn
	Title: Director

V-SCIENCES INVESTMENTS PTE LTD
By:	/s/ Khoo Shih
	Name: Khoo Shih
	Title: Authorised Signatory